Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections. Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] Journal article

Abstract
Full Citation
Full Text
Related Articles
Email this Abstract

Patel GW, Patel N, Lat A, Trombley K, Enbawe S, Manor K, Smith R, Lodise TP
Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections. [Journal Article]
Diagn Microbiol Infect Dis 2009 Jun; 64(2):236-40.

This comparison of intermittent versus extended-infusion piperacillin-tazobactam among patients with Gram-negative infections revealed similar mortality and length of stay. Outcomes remained similar when stratified by MIC value.

More from this journal

Diagnostic microbiology and infectious disease

[Diagn Microbiol Infect Dis]

Advertise on this site.